Regulus Therapeutic News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.03.17	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Regulus Therapeutics, Inc. To Contact The Firm Before Imminent Lead Plaintiff Deadline (PR Newswire)
28.03.17	Gainers & Losers Of Mar.27: APOP, IPXL, ZIOP, FOMX... (RTTNews)
23.03.17	Research Reports Initiation on Biotech Stocks -- Sangamo, Eyegate Pharma, Synthetic Biologics, and Regulus (PR Newswire)
13.03.17	RGLS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Regulus Therapeutics Inc. and a Lead Plaintiff Deadline of April 3, 2017 (PR Newswire)
23.02.17	Regulus to Release Fourth Quarter and Full Year 2016 Financial Results on March 2, 2017 (PR Newswire)
17.02.17	Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and... (PR Newswire)
08.02.17	Regulus to Present at Upcoming Healthcare Conferences (PR Newswire)
04.02.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Regulus Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline -- RGLS (PR Newswire)
31.01.17	Gainers & Losers Of The Day: CALA, EVOK, EYEG, OCRX, TENX... (RTTNews)
30.01.17	REGULUS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Regulus Therapeutics Inc. To Contact The Firm (PR Newswire)
30.01.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regulus Therapeutics Inc. - RGLS (PR Newswire)
30.01.17	RGLS Disappointed, NOVN Loses Face Over Acne Trial Data, AMGN Abuzz (RTTNews)
27.01.17	Regulus Announces Continuation of RG-101 Clinical Hold (PR Newswire)
20.01.17	Research Reports Initiation on Biotech Stocks -- Regulus Therapeutics, Abeona Therapeutics, Theravance Biopharma, and Sage Therapeutics (PR Newswire)
13.12.16	Research Reports Initiation on Biotech Stocks -- CorMedix, Trevena, Regulus Therapeutics, and ImmunoCellular Therapeutics (PR Newswire)
06.12.16	Regulus Announces New Drug Development Candidates (PR Newswire)
22.11.16	Regulus to Announce New Drug Development Candidates at R&D Day on December 6, 2016 (PR Newswire)
28.06.16	AKER Up On Aero-Med Deal, Allergy Under The Weather, RGLS Falls On Clinical Hold (RTTNews)
01.06.16	Regulus Therapeutics Expands Clinical Trial Collaboration With GSK (RTTNews)
22.01.16	AMGN Gets FDA Nod, Data Awaits RGLS In Feb, FORWARD Puts ALKS On The Back Foot (RTTNews)
02.06.15	Regulus CEO Kleanthis Xanthopoulos Resigns, Paul Grint Succeeds (RTTNews)
25.04.15	Regulus Therapeutics Presents New Data Strengthening Profile Of RG-101 (RTTNews)
08.04.15	RGLS Up After Hours, GLYC Has Some Good News, Panther On The Prowl (RTTNews)
06.08.14	GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date (RTTNews)
05.03.14	Regulus Therapeutics Commences Dosing RG-101 - Quick Facts (RTTNews)
19.02.14	Regulus Therapeutics Advances Orphan Disease Portfolio For Alport Syndrome (RTTNews)
21.11.13	PETX On The Move, IMGN To Pocket $5Mln, RGLS Gets Richer, MYGN Does It Again (RTTNews)
13.11.13	RegulusTherapeutics Q3 Loss Narrows (RTTNews)
05.11.13	ACUR To Meet With FDA, CYTX Does A Deal, NNVC Renews Contract, RGLS On Watch (RTTNews)
29.10.13	INCY's Got More Proof, AKRX Hits New High, ILMN Opens Wallet, RGLS On Watch (RTTNews)
13.08.13	Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights (PR Newswire)
06.08.13	Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call (PR Newswire)
17.07.13	RegulusTherapeutics Prices Public Offering Of 4.50 Mln Shares At $9.50/shr (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	81.30	1.75 %	K V
Lonza Grp	587.20	1.17 %	K V
Part Grp Hldg	1’395.00	1.01 %	K V
Novartis	90.43	0.78 %	K V
Kuehne+Nagel Int	206.00	0.68 %	K V
Sika	227.70	-0.31 %	K V
Geberit	499.20	-0.32 %	K V
ABB	53.34	-0.41 %	K V
Sonova Hldg	316.30	-0.69 %	K V
Givaudan	3’915.00	-0.76 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Regulus Therapeutic Inc

Aktien Top/Flop

Meistgelesene Nachrichten